| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.33▲ | 5.46▼ | 5.46▼ | 5.59▲ | 6.08▼ |
| MA10 | 5.51▼ | 5.58▼ | 5.60▼ | 5.67▲ | 6.70▼ |
| MA20 | 5.65▼ | 5.79▼ | 5.93▼ | 5.95▼ | 7.05▼ |
| MA50 | 6.65▼ | 6.76▼ | 6.77▼ | 6.65▼ | N/A |
| MA100 | 6.64▼ | 6.98▼ | 7.08▼ | 7.06▼ | N/A |
| MA200 | 7.13▼ | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.010▲ | -0.011▼ | 0.027▲ | N/A |
| RSI | 43.133▼ | 41.150▼ | 40.166▼ | 46.432▼ | 33.209▼ |
| STOCH | 16.036▼ | 34.412 | 34.412 | 32.886 | 15.493▼ |
| WILL %R | -59.843 | -59.843 | -59.843 | -32.886 | -78.261▼ |
| CCI | -39.285 | -60.405 | -64.027 | 14.475 | -147.971▼ |
|
Friday, February 13, 2026 05:13 AM
Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced the closing of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 5.36 | 5.90 | 5.36 | 5.90 | 3,015 |
| 12/02/26 | 5.60 | 5.60 | 5.60 | 5.60 | 0 |
| 11/02/26 | 5.30 | 5.60 | 5.30 | 5.60 | 1,851 |
| 10/02/26 | 5.80 | 5.80 | 4.90 | 5.44 | 9,000 |
| 09/02/26 | 5.97 | 6.02 | 5.40 | 5.40 | 3,400 |
| 06/02/26 | 5.955 | 6.30 | 5.44 | 5.44 | 6,400 |
| 05/02/26 | 5.80 | 5.80 | 5.80 | 5.80 | 0 |
| 04/02/26 | 6.00 | 6.00 | 5.80 | 5.80 | 1,000 |
| 03/02/26 | 5.51 | 6.39 | 5.50 | 6.17 | 4,000 |
| 02/02/26 | 5.74 | 5.85 | 5.502 | 5.502 | 5,771 |
|
|
||||
|
|
||||
|
|